Beijing: China is advancing the development of Covid-19 vaccines against variants of the novel coronavirus and experiments have shown the inactivated vaccines currently used in the country are effective against them.
Zhang Yuntao, vice-president of China National Biotech Group, a subsidiary of state-owned pharmaceutical giant Sinopharm, told a news conference on Sunday that researchers had been testing the antiviral-mutation ability of the inactivated vaccines.
Already a subscriber? Log in
Play, subscribe and stand a chance to win prizes worth over RM39,000! T&C applies.
Cancel anytime. Ad-free. Unlimited access with perks.
